$2.12
$2.02
$8.29
$1.11
$11.7M
-70.56%
This is a preview of the full version of Prosperse
GeoVax Labs, a clinical-stage biotechnology company, announced a $5 million registered direct offering of its common stock and warrants. The proceeds will be used for working capital and general corporate purposes.
N/A
Aug 29, 2024
GeoVax Labs, a clinical-stage biotechnology company, announced a $8.5 million registered direct offering of 1.7 million shares at $5 per share. The company will also issue warrants to purchase an additional 1.7 million shares at $5 per share. The proceeds will be used for working capital and general...
N/A
Aug 20, 2024
Date: Oct 21, 2024
Date: Oct 21, 2024
Date: Oct 21, 2024
Date: Oct 21, 2024
Date: Oct 21, 2024